Physician
Caring for Kids Pediatrics, PA
Caring for Kids Pediatrics, PA was paid $5.41M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoCARING FOR KIDS PEDIATRICS, PA
SAN ANTONIO, TX 78205
SAN ANTONIO, TX 78205
33aNPI1093970550assigned 07/24/2008
33bProvider typePediatrics Physician
28Total paid$5.41M
24GClaims292,809
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#75 of 1,136
Median peer was paid$329K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 545 | $6K | |
| 2019 | 824 | $10K | |
| 2020 | 19,081 | $337K | |
| 2021 | 92,360 | $1.55M | |
| 2022 | 80,097 | $1.47M | |
| 2023 | 64,702 | $1.25M | |
| 2024incomplete | 35,200 | $788K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 33,673 | 31,514 | $1.13M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 10,295 | 10,163 | $769K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 13,744 | 13,073 | $638K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 12% | 8,083 | 7,988 | $637K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.3% | 45,811 | 19,352 | $447K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.9% | 5,810 | 5,750 | $427K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 3,733 | 3,489 | $295K |
| S8301 | Infection control supplies, not otherwise specified | 3.8% | 20,562 | 19,081 | $208K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.6% | 2,761 | 2,635 | $194K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.6% | 18,354 | 15,015 | $142K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.9% | 3,738 | 3,597 | $102K |
| 90461 | 1.2% | 16,933 | 10,073 | $66K |
53 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 2,780 | $63K |
| 99000 | 1.0% | 6,214 | $55K | |
| 99381 | <1% | 564 | $45K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,087 | $41K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,471 | $23K |
| 83655 | <1% | 2,319 | $23K | |
| 92551 | <1% | 13,318 | $19K | |
| CP002 | <1% | 1,498 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 777 | $10K |
| 87631 | <1% | 99 | $9K | |
| 97169 | <1% | 360 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 544 | $8K |
| 96161 | <1% | 3,286 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 843 | $6K |
| 87807 | <1% | 489 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 96 | $5K |
| 99174 | <1% | 18,531 | $5K | |
| 85014 | <1% | 1,951 | $3K | |
| 85018 | <1% | 4,084 | $3K | |
| 94760 | <1% | 6,295 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 160 | $2K |
| 81003 | <1% | 608 | $1K | |
| 87634 | <1% | 24 | $766.61 | |
| 94010 | <1% | 13 | $227.15 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 25 | $196.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20 | $184.16 |
| 36416 | <1% | 1,207 | $25.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $25.44 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 58 | $21.45 |
| 90686 | <1% | 9,762 | $18.54 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 98 | $8.88 |
| 99173 | <1% | 462 | $6.01 | |
| 90648 | <1% | 5,389 | $5.13 | |
| 90661 | <1% | 749 | $0.68 | |
| 90633 | <1% | 3,020 | $0.05 | |
| 90670 | <1% | 4,790 | $0.04 | |
| 90680 | <1% | 3,445 | $0.02 | |
| 90723 | <1% | 3,773 | $0.02 | |
| 90716 | <1% | 774 | $0.01 | |
| 90651 | <1% | 1,451 | $0.01 | |
| 90734 | 0% | 939 | $0.00 | |
| 90707 | 0% | 781 | $0.00 | |
| 90700 | 0% | 937 | $0.00 | |
| 90671 | 0% | 352 | $0.00 | |
| 90710 | 0% | 1,068 | $0.00 | |
| 94664 | 0% | 61 | $0.00 | |
| 90715 | 0% | 351 | $0.00 | |
| 99072 | 0% | 247 | $0.00 | |
| 96160 | 0% | 42 | $0.00 | |
| 90696 | 0% | 826 | $0.00 | |
| 94761 | 0% | 31 | $0.00 | |
| 90677 | 0% | 114 | $0.00 | |
| 90620 | 0% | 109 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFERRER, ARACELY (PRESIDENT)